23.90
Alamar Biosciences Inc stock is traded at $23.90, with a volume of 122.66K.
It is up +0.59% in the last 24 hours and up +0.00% over the past month.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
See More
Previous Close:
$23.76
Open:
$23.67
24h Volume:
122.66K
Relative Volume:
1.78
Market Cap:
$1.63B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.46%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Alamar Biosciences Inc Stock (ALMR) Company Profile
Name
Alamar Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALMR
Alamar Biosciences Inc
|
23.90 | 1.62B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
|
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Alamar Biosciences Inc Stock (ALMR) Latest News
Investors can watch Alamar's BofA Healthcare Conference webcast May 12 - Stock Titan
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewswire
Alamar Biosciences Inc - Reuters
Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs - Sahm
ALMR SEC FilingsAlamar Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Proteomics firm Alamar climbs 40% after upsized IPO - MSN
Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026 - The Manila Times
From drought to demand: Biotech IPOs roar back with Kailera and Alamar - MSN
GLP-1 developer Kailera, proteomics firm Alamar file for US IPOs - MSN
Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut - MSN
Alamar Biosciences Inc. (ALMR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Proteomics firm Alamar prices upsized IPO at $17 per share - MSN
What is the current Price Target and Forecast for Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Nicholas Naclerio Discloses Investment at Alamar Biosciences with 9.6% Stake - TradingView
Illumina funds report 9.6% Alamar Biosciences (ALMR) stake after IPO - Stock Titan
Frank M. Sands discloses investment in Alamar Biosciences with 6.3% stake - TradingView
Sands Capital discloses 6.3% Alamar Biosciences (ALMR) stake and lock-up - Stock Titan
Qiming funds (ALMR) convert preferred stakes into common stock - Stock Titan
ALMR: Alamar Biosciences, Inc.Brokerage Recommendations Chart - Zacks Investment Research
Alamar Biosciences, Inc. Dividends – NASDAQ:ALMR - TradingView
Long term debt to total equity ratio of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Cash from operating activities of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Average basic shares outstanding of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Diluted shares outstanding of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Free cash flow of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Number of employees of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Cathie Wood Is Buying Up Alamar Biosciences Stock After Its IPO. Should You Snag Proteomics-Focused ALMR Too? - inkl
Operating income of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Non-controlling/minority interest of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Net income before discontinued operations of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Diluted earnings per share (diluted EPS) of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
EBITDA of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Equity in earnings of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Taxes of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Total revenue of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Pretax income of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Gross profit of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Diluted net income available to common stockholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Non-operating income (total) of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
EBIT of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Operating expenses (excl. COGS) of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Cost of goods sold of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Preferred dividends of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Total operating expenses of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
After tax other income/expense of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Gross margin % of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Price to book ratio of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Price to sales ratio of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Operating margin % of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Net current asset value per share of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Cash per share of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Inc Stock (ALMR) Financials Data
There is no financial data for Alamar Biosciences Inc (ALMR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):